A Comparative Study of FV-100 vs. Valacyclovir for the Prevention of Post-Herpetic Neuralgia
Condition: ShinglesInterventions: Drug: FV-100; Drug: valacyclovirSponsor: ContraVir Pharmaceuticals, Inc.Not yet recruiting - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 23, 2015 Category: Research Source Type: clinical trials
Valacyclovir to Prevent Vertical Transmission of Cytomegalovirus After Maternal Primary Infection During Pregnancy
Condition: Congenital Cytomegalovirus InfectionInterventions: Drug: Valacyclovir; Drug: PlaceboSponsor: Rabin Medical CenterNot yet recruiting - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 18, 2015 Category: Research Source Type: clinical trials
A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia
Condition: SchizophreniaInterventions: Drug: Valacyclovir HCI 500 mg tablets; Drug: placeboSponsors: Indiana University; Stanley Medical Research Institute; Sheppard Pratt Health System; University of Maryland; Centers for Behavioral Health, LLC; Laureate Institute for Brain Research, Inc.; University of Kansas Medical Center Research Institute, Inc.Recruiting - verified February 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 7, 2013 Category: Research Source Type: clinical trials
ValGanciclovir Versus ValAcyclovir for Viral Prophylaxis in Kidney Transplantation
Conditions: Transplantation Infection; Epstein-Barr Virus Infections; Cytomegalovirus InfectionsInterventions: Drug: Valacyclovir; Drug: ValganciclovirSponsor: University of Minnesota - Clinical and Translational Science InstituteRecruiting - verified May 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 10, 2013 Category: Research Source Type: clinical trials